Seeking Alpha

Celsion (CLSN -11.4%) sinks again today after noting in a SEC filing that it's entered into a...

Celsion (CLSN -11.4%) sinks again today after noting in a SEC filing that it's entered into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald to sell $25M worth of shares, from time to time. The stock cratered last week on news that its liver cancer drug TheromDox had failed its latest clinical trials.
From other sites
Comments (2)
  • Nahodny Okoloiduci
    , contributor
    Comments (146) | Send Message
     
    OK current pps is $1.15 so it means dilution by 21M newly issued shares. That's quite a 2/3 of shares outstanding as of today. Just wow.
    4 Feb 2013, 12:51 PM Reply Like
  • hdavidfrancis
    , contributor
    Comment (1) | Send Message
     
    Are these guys at Celsion wearing masks? They should be held up for fraud as a small shareholder, they are wearing my patience and my wallet shin- H. David Francis, Pharm D
    5 Feb 2013, 06:10 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector